FOXM1 and hepatocellular carcinoma: Using a cut-off at 8-fold difference between HCC and NT, 80 of the 118 HCC cases (67.8%) showed an overexpression of FOXM1, and 75 of the 118 HCC cases (63.6%) showed an overexpression of CENPF, whereas only 2 HCC cases (1.69%) had under-expression of either FOXM1 or CENPF.